Literature DB >> 25299970

Thrombophilic risk factors are uncommon in young patients with retinal vein occlusion.

Jasmina Ahluwalia1, Sandeep Rao, Subhash Varma, Amod Gupta, Sunil Bose, Joseph Masih, Reena Das, Narender Kumar, Shano Naseem, Prashant Sharma, Man Updesh Singh Sachdeva, Neelam Varma.   

Abstract

PURPOSE: To study the thrombotic factors, namely deficiencies of plasma proteins C, S, and antithrombin, factor V Leiden mutation, and positivity for antiphospholipid antibodies in young patients with retinal vein occlusion.
METHODS: The thrombophilia parameters listed above were analyzed from the laboratory records of 50 patients with the clinical diagnosis of retinal vein occlusion, aged less than 50 years.
RESULTS: A single prothrombotic factor was seen in 2 (4%) cases. The highest positivity was for the antiphospholipid antibodies (lupus anticoagulant in 6%, anticardiolipin antibodies in 2%, and anti-β 2 glycoprotein 1 in 10% cases). Other than one case where antiphospholipid syndrome was confirmed, these were transient. One patient had antithrombin deficiency. Protein C and protein S deficiency and factor V Leiden mutation were not seen in this group.
CONCLUSION: Our data suggest that these thrombophilia risk factors are not commonly associated with retinal vein occlusion, and there is a need for studies on other factors that contribute to the development of this condition.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25299970     DOI: 10.1097/IAE.0000000000000366

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  4 in total

Review 1.  [Retinal vein occlusion : Epidemiology, classification and clinical findings].

Authors:  N Feltgen; A Pielen
Journal:  Ophthalmologe       Date:  2015-07       Impact factor: 1.059

Review 2.  Clinical Features of Central Retinal Vein Occlusion in Young Patients.

Authors:  Xiao-Tong Zhang; Yi-Fan Zhong; Yan-Qi Xue; Si-Qi Li; Bing-Yu Wang; Gui-Qi Zhang; Iko Hidasa; Han Zhang
Journal:  Ophthalmol Ther       Date:  2022-06-13

3.  Hypercoagulability Testing and Hypercoagulable Disorders in Young Central Retinal Vein Occlusion Patients.

Authors:  Zujaja Tauqeer; Peter Bracha; Brendan McGeehan; Brian L VanderBeek
Journal:  Ophthalmol Retina       Date:  2021-03-24

4.  Systemic abnormalities associated with retinal vein occlusion in young patients.

Authors:  Suthasinee Sinawat; Chavisa Bunyavee; Tanapat Ratanapakorn; Supat Sinawat; Wipada Laovirojjanakul; Yosanan Yospaiboon
Journal:  Clin Ophthalmol       Date:  2017-02-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.